{"id":"https://openalex.org/W4245781982","doi":"https://doi.org/10.1158/1538-7445.am10-1672","title":"Abstract 1672: The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates","display_name":"Abstract 1672: The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W4245781982","doi":"https://doi.org/10.1158/1538-7445.am10-1672"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am10-1672","doi":"https://doi.org/10.1158/1538-7445.am10-1672","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-1672","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044409970","display_name":"AeRang Kim","orcid":"https://orcid.org/0000-0002-7813-5568","observed_orcids":["https://orcid.org/0000-0002-7813-5568"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"AeRang Kim","raw_affiliation_strings":["1National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034404939","display_name":"Cindy McCully","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cindy McCully","raw_affiliation_strings":["1National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rafael Cruz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rafael Cruz","raw_affiliation_strings":["1National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075130859","display_name":"Diane E. Cole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diane E. Cole","raw_affiliation_strings":["1National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057328309","display_name":"Elizabeth Fox","orcid":"https://orcid.org/0000-0003-1599-6069","observed_orcids":["https://orcid.org/0000-0003-1599-6069"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Fox","raw_affiliation_strings":["1National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024249524","display_name":"Frank M. Balis","orcid":"https://orcid.org/0000-0002-8117-6926","observed_orcids":["https://orcid.org/0000-0002-8117-6926"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank M. Balis","raw_affiliation_strings":["2Children's Hospital of Philadelphia, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Children's Hospital of Philadelphia, Philadelphia, PA","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071679104","display_name":"Brigitte C. Widemann","orcid":"https://orcid.org/0000-0002-9198-7175","observed_orcids":["https://orcid.org/0000-0002-9198-7175"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brigitte C. Widemann","raw_affiliation_strings":["1National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"8_Supplement","first_page":"1672","last_page":"1672"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.4207000136375427,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.4207000136375427,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.12600000202655792,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.07720000296831131,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-penetration","display_name":"cerebrospinal fluid penetration","score":0.9570000171661377},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.7490000128746033},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.8450000286102295},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.890999972820282},{"id":"https://openalex.org/keywords/brain-tumor-treatment","display_name":"brain tumor therapy","score":0.578000009059906},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.8450000286102295},{"id":"https://openalex.org/keywords/ommaya-reservoir","display_name":"Ommaya reservoir","score":0.6940000057220459},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.38999998569488525},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.4869999885559082},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.5989999771118164},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.8970000147819519},{"id":"https://openalex.org/keywords/animal-models","display_name":"animal models","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9576346278190613},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8731454610824585},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.6655158996582031},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6315144300460815},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6147213578224182},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.40907347202301025},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32254451513290405}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am10-1672","doi":"https://doi.org/10.1158/1538-7445.am10-1672","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-1672","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2013770585","https://openalex.org/W2047030258","https://openalex.org/W3016645340","https://openalex.org/W2058819067","https://openalex.org/W4308976561","https://openalex.org/W4248007672","https://openalex.org/W2891328919","https://openalex.org/W2047340990","https://openalex.org/W2809016054","https://openalex.org/W2986071592"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Sorafenib":[2,30,75,116,231],"is":[3,31,232,250],"an":[4,64,242],"oral":[5],"multikinase":[6],"inhibitor":[7],"that":[8],"targets":[9],"intracellular":[10],"and":[11,22,38,45,55,91,100,106,134,139,202,237,255,261],"receptor":[12],"protein":[13,174,222],"kinases":[14],"thought":[15],"to":[16,94,253],"be":[17],"crucial":[18],"in":[19,43,68,88,185,198,206,235,239,259,266],"the":[20,53,155,186,207,224,290,295],"pathogenesis":[21],"growth":[23],"of":[24,61,130,180,190,196,214,248,264,289,294],"many":[25],"tumors":[26,48],"including":[27],"brain":[28,47],"tumors.":[29],"FDA":[32],"approved":[33],"for":[34,113,132,171,200,220,298],"advanced":[35],"renal":[36],"cell":[37],"hepatocellular":[39],"carcinoma.":[40],"Clinical":[41],"trials":[42],"primary":[44],"metastatic":[46],"are":[49,204],"ongoing.":[50],"We":[51],"evaluated":[52],"plasma":[54,105,133,173,201,221,268,272],"cerebrospinal":[56],"fluid":[57],"(CSF)":[58],"pharmacokinetics":[59],"(PK)":[60],"sorafenib":[62,181,197,215,249,265],"after":[63,241],"intravenous":[65],"(IV)":[66],"dose":[67],"a":[69,84,120],"non-human":[70],"primate":[71],"(NHP)":[72],"model.":[73],"Methods:":[74],"7.3":[76],"mg":[77],"free":[78,162,256],"base":[79],"equivalent/kg":[80],"was":[81,117,136,152,182,216,228],"administered":[82],"as":[83],"1h":[85],"IV":[86,98,178,243],"infusion":[87],"20%":[89],"cyclodextrin":[90],"normal":[92],"saline":[93],"3":[95],"NHP":[96,187,199,236],"with":[97,119],"catheters":[99],"Ommaya":[101],"reservoirs.":[102],"Serial":[103],"paired":[104],"CSF":[107,135,150,157,203,212,226,240,246,262,274,277],"samples":[108],"were":[109,145,166],"drawn":[110],"over":[111],"24h":[112],"PK":[114,143,194,263],"analysis.":[115],"quantified":[118],"validated":[121],"liquid":[122],"chromatography/tandem":[123],"mass":[124],"spectrometry":[125],"assay.":[126],"The":[127,193,210,245],"lower":[128],"limit":[129],"quantification":[131],"5":[137],"ng/mL":[138],"0.025":[140],"ng/mL,":[141],"respectively.":[142],"parameters":[144,195],"estimated":[146],"using":[147],"non-compartmental":[148],"methods.":[149],"penetration":[151,213,227,247,279],"calculated":[153,167],"from":[154,168],"AUC":[156,159],":":[158],"plasma.":[160],"Plasma":[161],"drug":[163,257],"exposures":[164],"(AUC)":[165],"published":[169],"values":[170],"human":[172],"binding":[175],"(99.5%).":[176],"Results:":[177],"administration":[179],"well":[183,233],"tolerated":[184,234],"without":[188],"evidence":[189],"clinical":[191],"toxicity.":[192],"described":[205],"table":[208],"below.":[209],"mean":[211,225],"0.02%.":[217],"When":[218],"corrected":[219],"binding,":[223],"3.4%.":[229],"Conclusions:":[230],"measureable":[238],"dose.":[244],"limited":[251],"relative":[252],"total":[254],"exposure":[258],"plasma.Plasma":[260],"NHPAnimalCmax":[267],"[\u00b5g/mL]Clearance":[269],"[mL/min/kg]AUC":[270],"0-24h":[271,276],"[\u00b5g\u2022h/mL]Cmax":[273],"[\u00b5g/mL]AUC":[275],"[\u00b5g\u2022h/mL]CSF":[278],"[%]17.62.231.20.000450.00420.01326.42.029.60.000580.00660.02233.41.323.20.000460.00340.015Mean5.81.728.00.000500.00480.02SD2.10.54.30.000070.00160.005":[280],"Citation":[281],"Format:":[282],"{Authors}.":[283],"{Abstract":[284],"title}":[285],"[abstract].":[286],"In:":[287],"Proceedings":[288],"101st":[291],"Annual":[292],"Meeting":[293],"American":[296],"Association":[297],"Cancer":[299,309],"Research;":[300],"2010":[301],"Apr":[302],"17-21;":[303],"Washington,":[304],"DC.":[305],"Philadelphia":[306],"(PA):":[307],"AACR;":[308],"Res":[310],"2010;70(8":[311],"Suppl):Abstract":[312],"nr":[313],"1672.":[314]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2022-05-12T00:00:00"}